Ezet Tablet (hyperlipidemia)

Primary hypercholesterolemia

Elevated total cholesterol (total-C), LDL-cholesterol (LDL-C), apo B protein (Apo B), and triglyceride (TG) in patients with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia. ) and as an adjunct to diet to reduce non-HDL-cholesterol and increase HDL-cholesterol (HDL-C).

Homozygous Familial Hypercholesterolemia (HoFH) Other lipid-lowering treatments (e.g., LDL-Apheresis) to reduce elevated total cholesterol and LDL-cholesterol in patients with homozygous familial hypercholesterolemia (HoFH).
Administer this drug as an adjuvant, or when other lipid-lowering treatments are not useful.
It has not been established that the benefit of atorvastatin outweighs the effect of atorvastatin in reducing cardiovascular morbidity and mortality. This drug has not been studied in Fredrickson types I, III, IV, and V of dyslipidemia.
Many risk factors must be considered when administering lipid-modifying drugs to patients at increased risk of arteriosclerotic vascular disease due to hypercholesterolemia. Lipid-control drugs should be used in conjunction with an appropriate diet (including restriction of saturated fat and cholesterol) and when the response to diet and other non-pharmacological measures is insufficient (see '15 of 'Precautions for Use'). Others, refer to the ‘Dyslipidemia treatment guideline (NCEP ATP III Guideline summary table)’ section).
Before administering this drug, other secondary causes of dyslipidemia (e.g. diabetes, hypothyroidism, obstructive liver disease, chronic renal failure, drugs that increase LDL-cholesterol and drugs that reduce HDL-cholesterol [progestin, anabolic steroid) , and corticosteroid]) should be checked, and secondary causes should be treated if necessary. Lipid testing should include total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides. If the triglyceride level is more than 400 mg/dL (more than 4.5 mmol/L), the LDL-cholesterol concentration must be measured by ultracentrifugation. If you are hospitalized for an acute coronary accident, lipids should be measured upon admission or within 24 hours after admission. This measurement can be used as a reference in starting LDL-lowering treatment before or upon discharge of the patient.

2) Usage, dosage

Atorvastatin Calcium Trihydrate Atorvastatin Calcium Trihydrate 43.4mg (40mg as Atorvastatin) Ezetimibe